PHVS Earnings & Financial Statements
Pharvaris N.V.
$29.64
-$0.38(-1.27%)
33
Overall
45
Value
20
Tech
34
Quality
Market Cap
$2.09B
Volume
349.06K
52W Range
$20.65 - $43.25
Target Price
$59.85
PHVS earnings and financial statements: Pharvaris N.V.'s income statement, balance sheet and cash flow statement, annual and quarterly.
PHVS Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cost of revenue | - | - | - | - | $54.14M |
| Operating income | -$169.82M | -$145.69M | -$96.91M | -$86.71M | -$54.11M |
| EBITDA | -$173.29M | -$132.13M | - | -$75.52M | -$42.82M |
| Net income | -$175.70M | -$134.22M | -$95.05M | -$76.33M | -$42.70M |
| EPS (diluted) | $-2.97 | $-2.48 | $-2.63 | - | - |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $301.45M | $291.37M | $398.69M | $167.73M | $212.09M |
| Total liabilities | $30.18M | $23.61M | $14.65M | $18.47M | $20.92M |
| Shareholders’ equity | $271.27M | $267.76M | $384.05M | $124.99M | $191.17M |
| Cash and equivalents | $291.68M | $280.73M | $391.23M | $161.84M | $209.35M |
| Long-term debt | $576.6K | $639.0K | $43.6K | $249.4K | $150.8K |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$137.07M | -$120.13M | -$93.05M | -$67.16M | -$44.60M |
| Capital expenditure | - | - | - | -$124.3K | -$130.0K |
| Free cash flow | -$137.24M | -$120.67M | -$93.14M | -$67.29M | -$44.73M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PHVS | $29.64 | -1.3% | 349.06K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |